353 related articles for article (PubMed ID: 16982632)
1. Tissue factor and its inhibitor in human non-crescentic glomerulonephritis--immunostaining vs plasma and urinary levels.
Naumnik B; Borawski J; Chyczewski L; Pawlak K; Mysliwiec M
Nephrol Dial Transplant; 2006 Dec; 21(12):3450-7. PubMed ID: 16982632
[TBL] [Abstract][Full Text] [Related]
2. Plasma tissue factor and tissue factor pathway inhibitor in patients with primary glomerulonephritis.
Lizakowski S; Zdrojewski Z; Jagodzinski P; Rutkowski B
Scand J Urol Nephrol; 2007; 41(3):237-42. PubMed ID: 17469034
[TBL] [Abstract][Full Text] [Related]
3. Tissue factor pathway inhibitor expression in human crescentic glomerulonephritis.
Cunningham MA; Ono T; Hewitson TD; Tipping PG; Becker GJ; Holdsworth SR
Kidney Int; 1999 Apr; 55(4):1311-8. PubMed ID: 10200995
[TBL] [Abstract][Full Text] [Related]
4. Renal expression of tissue factor pathway inhibitor and evidence for a role in crescentic glomerulonephritis in rabbits.
Erlich JH; Apostolopoulos J; Wun TC; Kretzmer KK; Holdsworth SR; Tipping PG
J Clin Invest; 1996 Jul; 98(2):325-35. PubMed ID: 8755641
[TBL] [Abstract][Full Text] [Related]
5. Tissue factor, tissue pathway factor inhibitor and risk factors of atherosclerosis in patients with chronic limbs ischemia: preliminary study.
Gosk-Bierska I; Wysokin Ski W; Karnicki K; Adamiec R
Int Angiol; 2008 Aug; 27(4):296-301. PubMed ID: 18677291
[TBL] [Abstract][Full Text] [Related]
6. Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients.
Falciani M; Gori AM; Fedi S; Chiarugi L; Simonetti I; Dabizzi RP; Prisco D; Pepe G; Abbate R; Gensini GF; Neri Serneri GG
Thromb Haemost; 1998 Mar; 79(3):495-9. PubMed ID: 9531029
[TBL] [Abstract][Full Text] [Related]
7. Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation.
Shimura M; Wada H; Wakita Y; Nakase T; Hiyoyama K; Nagaya S; Mori Y; Shiku H
Am J Hematol; 1996 Jul; 52(3):165-70. PubMed ID: 8756081
[TBL] [Abstract][Full Text] [Related]
8. [Value of plasma tissue factor, tissue factor pathway inhibitor and factor VII assessments in patients with acute myocardial and cerebral infarction].
Xiong SL; Wang Q; Zheng L; Li JL; Wen ZB; He SL
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Dec; 27(12):1821-3. PubMed ID: 18158992
[TBL] [Abstract][Full Text] [Related]
9. Tissue factor pathway inhibitor (TFPI) levels in the plasma and urine of children with meningococcal disease.
Eling M; Stephens AC; Oragui EE; Rivers RP; Levin M
Thromb Haemost; 2001 Feb; 85(2):240-4. PubMed ID: 11246540
[TBL] [Abstract][Full Text] [Related]
10. DNA fragmentation in chronic glomerulonephritis: an immunohistological analysis.
Ott U; Aschoff A; Pocock J; Fünfstück R; Jirikowski G; Stein G; Wolf G
Nephron Clin Pract; 2007; 105(1):c18-28. PubMed ID: 17114899
[TBL] [Abstract][Full Text] [Related]
11. [Levels of plasma TF and TFPI activities in patients with acute leukemia].
Zhu Y; Xie ZX; He XF; Han JZ; Li JC; He SL
Hunan Yi Ke Da Xue Xue Bao; 2000 Aug; 25(4):401-2, 405. PubMed ID: 12206017
[TBL] [Abstract][Full Text] [Related]
12. Tissue factor initiates glomerular fibrin deposition and promotes major histocompatibility complex class II expression in crescentic glomerulonephritis.
Erlich JH; Holdsworth SR; Tipping PG
Am J Pathol; 1997 Mar; 150(3):873-80. PubMed ID: 9060825
[TBL] [Abstract][Full Text] [Related]
13. The relationship between plasma and placental tissue factor, and tissue factor pathway inhibitors in severe pre-eclampsia patients.
Teng Y; Jiang R; Lin Q; Ding C; Ye Z
Thromb Res; 2010 Jul; 126(1):e41-5. PubMed ID: 20226500
[TBL] [Abstract][Full Text] [Related]
14. Tissue factor reduction and tissue factor pathway inhibitor release after heparin administration.
Gori AM; Pepe G; Attanasio M; Falciani M; Abbate R; Prisco D; Fedi S; Giusti B; Brunelli T; Giusti B; Brunelli T; Comeglio P; Gensini GF; Neri Serneri GG
Thromb Haemost; 1999 Apr; 81(4):589-93. PubMed ID: 10235445
[TBL] [Abstract][Full Text] [Related]
15. Tissue factor, tissue factor pathway inhibitor and vascular endothelial growth factor-A in carotid atherosclerotic plaques.
Migdalski A; Kotschy M; Jawien A
Eur J Vasc Endovasc Surg; 2005 Jul; 30(1):41-7. PubMed ID: 15933981
[TBL] [Abstract][Full Text] [Related]
16. Tissue factor/its pathway inhibitor system and kynurenines in chronic kidney disease patients on conservative treatment.
Pawlak K; Tankiewicz J; Mysliwiec M; Pawlak D
Blood Coagul Fibrinolysis; 2009 Oct; 20(7):590-4. PubMed ID: 19491664
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of plasma tissue factor and tissue factor pathway inhibitor levels in childhood hemangiomas.
Türker M; Irken G; Oren H; Yilmaz S; Yüksel F; Olgun N
Pediatr Blood Cancer; 2006 Dec; 47(7):914-7. PubMed ID: 16395682
[TBL] [Abstract][Full Text] [Related]
18. Decreased plasma tissue factor pathway inhibitor levels in patients with thrombotic thrombocytopenic purpura.
Kobayashi M; Wada H; Wakita Y; Shimura M; Nakase T; Hiyoyama K; Nagaya S; Minami N; Nakano T; Shiku H
Thromb Haemost; 1995 Jan; 73(1):10-4. PubMed ID: 7740478
[TBL] [Abstract][Full Text] [Related]
19. Glomerular tissue factor expression in crescentic glomerulonephritis. Correlations between antigen, activity, and mRNA.
Tipping PG; Erlich JH; Apostolopoulos J; Mackman N; Loskutoff D; Holdsworth SR
Am J Pathol; 1995 Dec; 147(6):1736-48. PubMed ID: 7495298
[TBL] [Abstract][Full Text] [Related]
20. [Effects of tissue factor pathway inhibitor-1 on no-reflow in a rabbit model].
Luo JG; Chen YD; Tian F; Wang CH; Lü Y; Yang XX; Lü SZ
Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Dec; 37(12):1113-8. PubMed ID: 20193184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
